On the verge of personalized medicine

Article

The day is fast approaching when doctors will be able to use genetic or molecular tests to personalize patients' pharmacological regimens. "Today, we are seeing the first applications (of genetic technology)," Robert Field, chairman of the health policy and public health department at the University of the Sciences in Philadelphia, told The Wall Street Journal (2/14/2007). "I think 5 years from now, certainly 10 years from now, this will indeed dominate medicine."

The day is fast approaching when doctors will be able to use genetic or molecular tests to personalize patients' pharmacological regimens. "Today, we are seeing the first applications (of genetic technology)," Robert Field, chairman of the health policy and public health department at the University of the Sciences in Philadelphia, told The Wall Street Journal (2/14/2007). "I think 5 years from now, certainly 10 years from now, this will indeed dominate medicine."

Already, there are personalized medications on the market-such as Genentech's Herceptin for breast cancer treatment and Novartis AG's Gleevec for leukemia treatment. In addition, a collaborative study-by Medco Health Solutions, Inc., and the Mayo Clinic-is under way to determine whether genetic testing can help "eliminate the life-threatening and costly complications" of warfarin.

Proponents of personalized medicine believe that such advances will make medicine safer, less costly, and more efficient. The promise of personalized medicine is that physicians would be able to customize therapies to fit a patient's genetic profile, determine appropriate medication dosages, and reduce harmful side effects, among other things. However, there are several issues that still need to be worked out: The technology raises several questions around insurance coverage for new diagnostic tests and therapies, regulatory standards, and privacy issues for patients.

Recent Videos
Devon Ramaeker, MD
Elizabeth Gandee, APRN-CNP, highlights gaps in women's menopause knowledge | Image Credit: wexnermedical.osu.edu
Doula highlights how postpartum care is failing new mothers | Image Credit: linkedin.com
Nicky Herrick MD; and Anushree Agarwal, MD, MBBS, highlight their study on cardiac arrhythmias in pregnancy | Image Credit: © Igor Borodin - stock.adobe.com.
Lisa Becht, MD, FACOG, sheds light on fertility awareness | Image Credit: havingbabies.com.
First US national HPV conference highlights advances in cancer prevention | Image Credit: uchealth.com.
Mitchell Creinin, MD, reports estetrol pill eases menstrual symptoms | Image Credit: health.ucdavis.edu
1 expert is featured in this series.
Susanna Mitro, PhD, reveals ethnic disparities in uterine fibroid diagnosis | Image Credit: divisionofresearch.kaiserpermanente.org.
Shayna Mancuso, DO, highlights the real impact of menopause | Image Credit: linkedin.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.